Bauer Jake
SEC insider (Form 3/4/5 filer). CIK 0001654909. Director at BridgeBio Oncology Therapeutics, Inc. (BBOT) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Bauer Jake has filed insider reports for
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Director
- Immunovant, Inc. (IMVT): Director
- Enliven Therapeutics, Inc. (ELVN): Director
Bauer Jake
CIK: 0001654909
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31.7K shares- - Apr 7, 2026IMVT
Immunovant, Inc.
AwardDirect13.9K shares- - Feb 12, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - Aug 26, 2025BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
138.2K shares- - May 1, 2025IMVT
Immunovant, Inc.
AwardDirect25K shares- - Feb 6, 2025ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,675 | - | - | Direct |
| Apr 7, 2026 |  IMVT Immunovant, Inc. | Award | 13,880 | - | $0 | Direct |
| Feb 12, 2026 |  ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 17,126 | - | - | Direct |
| Aug 26, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 138,193 | - | - | Direct |
| May 1, 2025 | IMVT Immunovant, Inc. | Award | 25,016 | - | - | Direct |
| Feb 6, 2025 | ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 20,491 | - | - | Direct |
1-6 of 6 transactions